ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of ...
EatingWell on MSN3h
7 Habits That Could Lower Your Dementia Risk, According to a New StudyThey may lower your risk of other neurodegenerative diseases, too. Reviewed by Dietitian Annie Nguyen, M.A., RD A new study ...
Zacks.com on MSN13h
Ionis Out-Licenses Rights for Rare Blood Cancer Drug to OnoPer the deal terms, IONS will receive an upfront payment of $280 million from Ono. It is also eligible for milestone payments of up to $660 million.
Despite being diagnosed with Amyotrophic Lateral Sclerosis, or ALS, a longtime coach at Northern Bedford County High School ...
Massachusetts, Cambridge Saturday, March 1, 2025, 18:00 Hrs [IST] ...
such as progressive primary lateral sclerosis, progressive muscular atrophy and progressive bulpar palsy. Blood phosphorylated (p)-tau 181 and p-tau 217 have been proposed as accurate biomarkers ...
Daily Express US on MSN4d
Motor neuron disease: Easy-to-dismiss symptom could be a sign of debilitating conditionMotor neuron diseases are a group of fatal progressive disorders that rob the body and brain of the ability to function.
Learn more about whether Ionis Pharmaceuticals, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...
We recently published a list of 12 Stocks with Heavy Insider Buying in 2025. In this article, we are going to take a look at ...
Study Finds on MSN2d
Researchers uncover serious flaw in promising Alzheimer’s blood testsNew research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback